Target intelligence / Profile preview

RNA, U2 small nuclear 34, pseudogene (RNU2-34P)

Target: RNU2-34P
Molecular classification: Other

Overview

RNA, U2 small nuclear 34, pseudogene (RNU2-34P) is a member of the U2 small nuclear RNA (snRNA) pseudogene family. U2 snRNAs are key components of the spliceosome involved in pre-mRNA splicing; however, pseudogenes like RNU2-34P are typically nonfunctional copies of these genes and are not transcribed into functional RNA or protein. As a pseudogene, RNU2-34P lacks demonstrated biological function, is not a therapeutic target, is not associated with disease roles, and does not have known drug interactions or biomarker relevance[1][4].

Other names: RNU2-34PU2 snRNA pseudogene 34

Beyond the preview

Go deeper on RNA, U2 small nuclear 34, pseudogene (RNU2-34P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 34, pseudogene (RNU2-34P).

Explore the full profile